Podcast · Episode 09

    FDA AI Guidance Explained: What It Means for Medical Device Cybersecurity

    With MedTech leader - How does the FDA’s latest AI guidance on medical devices impact manufacturers and cybersecurity challenges in healthcare?

    Listen hereOpen audio file
    Christian Espinosa, Founder & CEO at Blue Goat Cyber

    By Christian Espinosa, MBA

    Founder & CEO · Blue Goat Cyber

    Listen now

    How does the FDA’s latest AI guidance on medical devices impact manufacturers and cybersecurity challenges in healthcare?

    In this episode, Christian discuss the latest FDA AI guidance and how it will impact real-world AI applications in healthcare.

    Key points:

    • The FDA’s new guidance on AI in medical devices, released in January 2025.

    • Differences between artificial intelligence (AI) and machine learning (ML).

    • Historical context of AI, including early examples like Microsoft’s Clippy.

    • Potential risks of AI in healthcare, including data poisoning, model inversion, and evasion.

    • Challenges of ensuring AI integrity, confidentiality, and availability.

    • The concept of model bias and how it impacts diagnostic accuracy.

    • Practical cybersecurity strategies for AI-enabled medical devices.

    • Importance of ongoing post-market monitoring to address performance drift.

    • Value of consulting cybersecurity experts early in the development lifecycle.

    Bring this work to your device

    Need help with fda premarket cybersecurity?

    Blue Goat Cyber delivers fda premarket cybersecurity services for medical device manufacturers - from threat modeling to FDA-ready reports.

    FDA Premarket Cybersecurity Services

    More on FDA Premarket Cybersecurity

    Ready when you are

    Get FDA cleared without the cybersecurity headaches.

    30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ devices supported.